Lupus Anticoagulant (LAC) testing in patients with inflammatory status: Does C-reactive protein interfere with LAC test results?

Thrombosis Research

Volumn 125, Issue 1, 2010, Pages 102-104

  Schouwers, Sofie M E ^a   Delanghe, Joris R ^a   Devreese, Katrien M J ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM CHLORIDE; CARDIOLIPIN ANTIBODY; CATECHOLAMINE; LUPUS ANTICOAGULANT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; THROMBIN;

ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; HUMAN; INFLAMMATION; INTENSIVE CARE; LETTER; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RANK SUM TEST; RETROSPECTIVE STUDY; SEPSIS;

ANTIPHOSPHOLIPID SYNDROME; C-REACTIVE PROTEIN; HUMANS; INFLAMMATION; LUPUS COAGULATION INHIBITOR;

EID: 76449100475     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.09.001     Document Type: Letter

References (14)

1. Miyakis S., Lockshin M.D., Atsumi D., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
2. Brandt J.T., Triplett D.A., Alving B., and Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 74 (1995) 1185-1190
3. Pengo V., Tripodi A., Reber G., Rand J.H., Ortel T.L., Galli M., et al. Official communication of the scientific and standardization committee on lupus anticoagulant/phospholipid-dependent antibodies: update of the guidelines for lupus anticoagulant detection. J Thromb Haemost (2009) 10.1111/j.1538-7836.2009.03555.x
4. Devreese K., and Hoylaerts M.F. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome. Eur J Haematol 83 (2009) 1-16
5. Volanakis J. Human C-reactive protein: expression, structure, and function. Mol Immunol 38 (2001) 189-197
6. van Tits L., de Graaf J., Toenhake H., van Heerde W., and Stalenhoef A. C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol 25 (2005) 717-722
7. Mi L.Z., Wang H.W., and Sui S.F. Interaction of rabbit C-reactive protein with phospholipid monolayers studied by microfluoresence film balance with an externally applied electric field. Biofys J 73 (1997) 446-451
8. Devreese K., Peerlinck K., Arnout J., and Hoylaerts M.F. Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography. Thromb Haemost 101 (2009) 185-196
9. Sailer T., Vormittad R., Pabinger I., Vukovich T., Lehr S., Quehenberger P., et al. Inflammation in patients with lupus anticoagulant and implications for thrombosis. J Rheumatol 32 (2005) 462-468
10. Sidelmann J., Sjoland J., Gram J., Bertelsen V., Mourits-Andersen T., Münster H., et al. Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis. Scand J Clin Lab Invest 67 (2007) 270-279
11. Wenzel C., Stoiser B., Locker G., Laczila K., Quehenberger P., Kapiotis S., et al. Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions. Crit Care Med 30 (2002) 763-770
12. Male C., Lechner K., Eichinger S., Kyrle P.A., Kapiotis S., Wank H., et al. Clinical significance of lupus anticoagulants in children. J Pediatr 134 (1999) 199-205
13. Male C., Lechner K., Speiser W., and Pabinger I. Transient Lupus Anticoagulants in children: Stepwis Disappearance of Diagnostic Features. Thromb Haemost 83 (2000) 174-175
14. Frauenknecht L., Lackner K., and von Landenberg P. Antiphospholipid antibodies in paediatric patients with prolonged activated partial thromboplastin time during infection. Immunobiology 210 (2005) 799-805